Breakeven On The Horizon For Akebia Therapeutics, Inc. (NASDAQ:AKBA)

With the business potentially at an important milestone, we thought we'd take a closer look at Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) future prospects. Akebia Therapeutics, Inc., a biopharmaceutic

Simply Wall St06:29 ET

Revenue Downgrade: Here's What Analysts Forecast For Akebia Therapeutics, Inc. (NASDAQ:AKBA)

Yahoo FinanceMay 11 09:21 ET

Akebia Therapeutics Reports Q1 2024 Financial Results: A Detailed Overview

Yahoo FinanceMay 10 15:27 ET

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 10 15:06 ET

Akebia Therapeutics First Quarter 2024 Earnings: Misses Expectations

Yahoo FinanceMay 10 09:19 ET

Akebia Therapeutics(AKBA.US) Officer Sells US$31,050 in Common Stock

$Akebia Therapeutics(AKBA.US)$ Officer Burke Steven Keith sold 27,000 shares of common stock on Aug 25, 2023 at an average price of $1.15 for a total value of $31,050.Source: Announcement What is stat

moomoo NewsMay 9 18:07 ET